No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer

Int J Cancer. 2000 Aug 1;87(3):455-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma / genetics*
  • DNA Mutational Analysis
  • DNA, Neoplasm / genetics
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Multiple Myeloma / epidemiology
  • Mutation, Missense*
  • Organ Specificity
  • Point Mutation*
  • Polymerase Chain Reaction
  • Prostatic Neoplasms / genetics*
  • Protein-Tyrosine Kinases*
  • Receptor, Fibroblast Growth Factor, Type 3
  • Receptors, Fibroblast Growth Factor / genetics*
  • Urinary Bladder Neoplasms / genetics
  • Uterine Cervical Neoplasms / genetics

Substances

  • DNA, Neoplasm
  • Receptors, Fibroblast Growth Factor
  • FGFR3 protein, human
  • Protein-Tyrosine Kinases
  • Receptor, Fibroblast Growth Factor, Type 3